History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Mathematical biology and pharmacology models have a long and rich history in the fields of medicine and physiology, impacting our understanding of disease mechanisms and the development of novel therapeutics. With an increased focus on the pharmacology application of system models and the advances in data science spanning mechanistic and empirical approaches, there is a significant opportunity and promise to leverage these advancements to enhance the development and application of the systems pharmacology field. In this paper, we will review milestones in the evolution of mathematical biology and pharmacology models, highlight some of the gaps and challenges in developing and applying systems pharmacology models, and provide a vision for an integrated strategy that leverages advances in adjacent fields to overcome these challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What is flux balance analysis?
Orth, J. D., Thiele, I., & Palsson, B. Ø. (2010) · Nature Biotechnology · doi:10.1038/nbt.1614 · Cited by 3,903
Caspi, R., Billington, R., Ferrer, L., Foerster, H., Fulcher, C. A., Keseler, I. M., Kothari, A., Krummenacker, M., Latendresse, M., Mueller, L. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1164 · Cited by 3,395
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0
Schellenberger, J., Que, R., Fleming, R. M. T., Thiele, I., Orth, J. D., Feist, A. M., Zielinski, D. C., Bordbar, A., Lewis, N. E., Rahmanian, S., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.308 · Cited by 1,835
A Whole-Cell Computational Model Predicts Phenotype from Genotype
Karr, J. R., Sanghvi, J. C., Macklin, D. N., Gutschow, M. V., Jacobs, J. M., Bolival, B., Assad-Garcia, N., Glass, J. I., & Covert, M. W. (2012) · Cell · doi:10.1016/j.cell.2012.05.044 · Cited by 1,300
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Circulation: Overall Regulation
Guyton, A. C., Coleman, T. G., & Granger, H. J. (1972) · Annual Review of Physiology · doi:10.1146/annurev.ph.34.030172.000305 · Cited by 870
Le Novere, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj092 · Cited by 762
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Lin, P. L., Ford, C. B., Coleman, M. T., Myers, A. J., Gawande, R., Ioerger, T., Sacchettini, J., Fortune, S. M., & Flynn, J. L. (2014) · Nature Medicine · doi:10.1038/nm.3412 · Cited by 533
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12134 · Cited by 425
Systems Biology: Constraint-based Reconstruction and Analysis
Palsson, B. Ø. (2015) · doi:10.1017/cbo9781139854610 · Cited by 210
SABIO-RK: an updated resource for manually curated biochemical reaction kinetics
Wittig, U., Rey, M., Weidemann, A., Kania, R., & Müller, W. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1065 · Cited by 204
Dynamics of open chemical systems and the algebraic structure of the underlying reaction network
Feinberg, M., & Horn, F. J. M. (1974) · Chemical Engineering Science · doi:10.1016/0009-2509(74)80195-8 · Cited by 171 · cited 1×
“Thus, the abundant know-how developed by systems biology (Palsson, 2015) and other research areas (Feinberg and Horn, 1974; Maeda et al., 1978; Biggs and Biggs, 1993; Jacquez and Simon, 1993; Caughman and Veerman, 2006; Klinke and Finley, 2012; Mirzaev and Gunawardena, 2013) is not translated into a large-scale use of…”
BackgroundFröhlich, F., Kessler, T., Weindl, D., Shadrin, A., Schmiester, L., Hache, H., Muradyan, A., Schütte, M., Lim, J.-H., Heinig, M., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.013 · Cited by 143 · cited 1×
“The number of publicly available omics datasets are constantly increasing, and they can be efficiently used to parameterize ordinary differential equation (ODE)based mechanistic models (Fröhlich et al., 2018).”
MethodFriedrich, C. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12056 · Cited by 87 · cited 2×
“…Maeda et al., 1978; Biggs and Biggs, 1993; Jacquez and Simon, 1993; Caughman and Veerman, 2006; Klinke and Finley, 2012; Mirzaev and Gunawardena, 2013) is not translated into a large-scale use of such models (Sorger et al., 2011; Friedrich, 2016) as an in silico substitute for clinical trials.”
BackgroundA blueprint for human whole-cell modeling
Szigeti, B., Roth, Y. D., Sekar, J. A. P., Goldberg, A. P., Pochiraju, S. C., & Karr, J. R. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.10.005 · Cited by 72
Path‐seq identifies an essential mycolate remodeling program for mycobacterial host adaptation
Peterson, E. J., Bailo, R., Rothchild, A. C., Arrieta‐Ortiz, M. L., Kaur, A., Pan, M., Mai, D., Abidi, A. A., Cooper, C., Aderem, A., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188584 · Cited by 63
Self-citationKirouac, D. C., Cicali, B., & Schmidt, S. (2019) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12390 · Cited by 46 · cited 1×
“, 2019b, 2020), especially as they pertain to the reproducibility of model outputs and model behavior (Kirouac et al., 2019).”
BackgroundKaddi, C. D., Niesner, B., Baek, R., Jasper, P., Pappas, J., Tolsma, J., Li, J., van Rijn, Z., Tao, M., Ortemann‐Renon, C., et al. (2018) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12304 · Cited by 36 · cited 1×
“QSP is a mechanistic modeling approach that is used for the assessment of therapeutic intervention on a disease by linking descriptions of the molecular and cellular mechanisms of the disease and drug to system-wide dynamics, bridging biomarkers and clinical endpoints relevant for the disease (Gadkar et al., 2016; Bal…”
MethodSelf-citationSimoni, G., Reali, F., Priami, C., & Marchetti, L. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1459 · Cited by 26
Self-citation
Cited by
Wang, H., Arulraj, T., Ippolito, A., & Popel, A. S. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01188-4 · Cited by 122
“…fi rst to accompany regulatory submissions, and, with advancing mechanistic understanding of pathophysiology and increasing computational power, mechanistic models, such as physiologically-based pharmacokinetic (PBPK) and quantitative systems pharmacology (QSP) models, were developed 2,3 .”
BackgroundTranslational PK–PD for targeted protein degradation
Bartlett, D. W., & Gilbert, A. M. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00114d · Cited by 55
Goryanin, I., Goryanin, I., & Demin, O. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104448 · Cited by 21
Folguera-Blasco, N., Boshier, F. A. T., Uatay, A., Pichardo-Almarza, C., Lai, M., Biasetti, J., Dearden, R., Gibbs, M., & Kimko, H. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1380685 · Cited by 15
Metadata
- Authors
- Azer, K., Kaddi, C. D., Barrett, J. S., Bai, J. P. F., McQuade, S. T., Merrill, N. J., Piccoli, B., Neves-Zaph, S., Marchetti, L., Lombardo, R., Parolo, S., Immanuel, S. R. C., & Baliga, N. S.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-25
- Volume
- 12
- Pages
- 637999-637999
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W3143891686
- Cited by
- 87
- References
- 21
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.